AptaBio Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	32,044	25,016	1,989
Short-Term Investments	1,019	19,000	15,026
Trading Asset Securities	4,921	8,869	-
Cash & Short-Term Investments	37,984	52,885	17,015
Cash Growth	-42.85%	210.81%	-
Other Receivables	114.51	366.31	224.46
Receivables	1,807	2,659	3,047
Prepaid Expenses	256.7	176.31	88.23
Other Current Assets	3,376	1,754	268.93
Total Current Assets	43,453	57,474	20,419
Property, Plant & Equipment	4,840	5,129	5,848
Long-Term Investments	28,461	23,779	27,885
Other Intangible Assets	44.6	61.09	37.83
Other Long-Term Assets	3,624	3,675	1,924
Total Assets	83,322	92,519	56,114
Accrued Expenses	356.87	337.19	455.54
Current Portion of Leases	135.7	131.08	109.73
Current Income Taxes Payable	-	1.48	-
Other Current Liabilities	16,862	348.2	474.75
Total Current Liabilities	17,370	817.95	1,040
Long-Term Debt	13,384	13,569	-
Long-Term Leases	174.88	233.45	256.3
Other Long-Term Liabilities	73.1	13,524	54.58
Total Liabilities	34,356	31,156	3,744
Common Stock	12,365	11,149	11,149
Additional Paid-In Capital	135,335	129,712	109,025
Retained Earnings	-99,739	-80,713	-68,473
Comprehensive Income & Other	1,005	696.38	668.63
Total Common Equity	48,967	60,845	52,370
Shareholders' Equity	48,967	61,363	52,370
Total Liabilities & Equity	83,322	92,519	56,114
Total Debt	13,695	13,934	366.03
Net Cash (Debt)	24,289	38,951	16,649
Net Cash Growth	-50.89%	133.95%	-
Net Cash Per Share	1079.91	1746.78	746.98
Filing Date Shares Outstanding	24.73	22.3	22.3
Total Common Shares Outstanding	24.73	22.3	22.3
Working Capital	26,083	56,656	19,379
Book Value Per Share	1980.03	2728.60	2348.53
Tangible Book Value	48,922	60,784	52,332
Tangible Book Value Per Share	1978.23	2725.86	2346.83
Land	1,787	1,787	1,922
Buildings	3,046	3,046	3,388
Machinery	1,199	1,196	1,101

Source: S&P Capital IQ. Standard template. Financial Sources.